Total planned funding: $1,298,924,514
Clear active filters
Chemonics International
Private Contractor
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Tanzania | $220,907,086 |
Zambia | $218,734,344 |
Nigeria | $198,491,982 |
Mozambique | $126,234,226 |
Kenya | $101,070,116 |
Uganda | $88,949,718 |
Zimbabwe | $64,124,420 |
Rwanda | $59,427,634 |
Haiti | $52,962,119 |
Democratic Republic of the Congo | $32,158,641 |
Ethiopia | $23,058,613 |
Côte d'Ivoire | $20,569,436 |
Ukraine | $15,523,612 |
Vietnam | $14,512,944 |
South Africa | $12,357,311 |
Malawi | $8,568,740 |
Eswatini | $8,024,998 |
Burundi | $5,158,717 |
Lesotho | $5,000,000 |
South Sudan | $4,590,759 |
Namibia | $3,458,687 |
Cameroon | $3,292,768 |
Angola | $3,017,189 |
Ghana | $2,760,959 |
Botswana | $2,329,808 |
Caribbean Region | $1,233,936 |
Indonesia | $900,001 |
Central America Region | $565,750 |
Burma | $550,000 |
Central Asia Region | $250,000 |
Cambodia | $140,000 |
Organizational Types
Private Contractor | $1,298,924,514 |
Program Areas
Treatment | $1,036,556,784 |
Care | $84,501,400 |
Prevention | $74,464,196 |
Governance and Systems | $67,192,981 |
Testing | $32,144,031 |
Budget Codes
HTXD: Treatment: ARV Drugs | $783,609,597 |
HTXS: Treatment: Adult Treatment | $234,814,504 |
OHSS: Health Systems Strengthening | $52,998,274 |
HBHC: Care: Adult Care and Support | $50,612,136 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $35,619,331 |
HVCT: Testing: HIV Testing and Counseling | $32,144,031 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $22,045,187 |
PDTX: Treatment: Pediatric Treatment | $18,132,683 |
HVTB: Care: TB/HIV | $14,689,379 |
PDCS: Care: Pediatric Care and Support | $14,051,584 |
HVOP: Sexual Prevention: Other Sexual Prevention | $12,136,102 |
HLAB: Laboratory Infrastructure | $11,401,779 |
HKID: Care: Orphans and Vulnerable Children | $5,148,301 |
HVSI: Strategic Information | $2,792,928 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $1,522,765 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $1,513,157 |
HMIN: Biomedical Prevention: Injection Safety | $1,153,631 |
HMBL: Biomedical Prevention: Blood Safety | $474,023 |
Top Partner Programs
Chemonics International:
$1,298,924,514
View countries